Etrials EDC to Interface with Green Mountain Logic Labpas CT
The interface provides a complete end-to-end solution for Phase I clinical research and shortens overall trial times while also improving data quality. LabPas CT, a full enterprise solution for the conduct of Phase I clinical trials, will automate key clinical trial data collection, make trial data available in real-time and electronically export validated data to etrials’ EDC. etrials’ EDC will provide a web-based, globally-proven solution for collecting, managing and analyzing real-time clinical trial information.
“Both etrials EDC and LabPas CT are highly regarded for their innovative, flexible and sophisticated, yet easy-to-use technology,” said John Rosenblum, CEO, GML. “The synergy between these solutions is extraordinary.”
“etrials’ partnership with GML is a great example of our joint commitment to helping clients’ accelerate their time-to-market,” Chip Jennings, president and CEO of etrials. “The integration of etrials EDC and LabPas CT demonstrates our companies’ deep understanding of our clients’ real-world challenges. The level of automation this technology interface provides can go a long way to streamlining Phase I clinical trials.”
About Green Mountain Logic and LabPas CT
Green Mountain Logic, located in Montpelier, Vermont, provides powerful, reliable, easy to use, targeted technology solutions to the life science industry. GML’s LabPas CT product comprehensively manages Phase I clinical trials, from recruiting through export to EDC. Unique in its intuitive use and adaptability to individual study protocols, LabPas CT increases margins, improves compliance and expands capabilities. In the last year, seven highly regarded CROs have selected LabPas CT to automate their Phase I studies. Additional information about LabPas CT is available at www.labpas.com.
About etrials Worldwide
With global operations, etrials Worldwide, Inc., is the only top tier solutions provider to offer EDC, eDiary and IVR as part of an integrated software-as-a-Service (SaaS) platform or as individual solutions to optimize clinical trials. As an experienced industry and technology leader, etrials has facilitated over 900 trials involving more than 400,000 patients in 60 countries; and has participated in 33 studies used for new drug applications. Having partnered with over 100 clients, including 16 of the top 20 global pharmaceutical companies and top CROs, etrials is leading the way in toward Adaptive Trials and integration between eClincal and electronic health records. Additional information about etrials Worldwide is available at www.etrials.com
Forward-Looking Statements
This announcement may contain forward-looking statements, including statements regarding the business and technology interface relationship covered by a new agreement. These statements involve risks and uncertainties. Actual results could differ materially from those discussed. Factors that could cause or contribute to such differences include, but are not limited to, delays in the current schedule for clinical trials by the client, utilization of our software and services by clients to a lesser degree than is currently expected and early termination of the contract, all of which are possible because our contracts do not generally have minimum volume guarantees and can be terminated without penalty by clients. More information about potential factors which could cause actual results to differ from the forward looking statements included in this announcement is included in our filings with the Securities and Exchange Commission, including the “Risk Factors” Section of the Form 10-KSB filed on March 30, 2007. All forward-looking statements are based on information available to us on the date hereof, and we assume no obligation to update such statements.
Contact
Pat Sears Vice President of Marketing Green Mountain Logic 802.223.9800 ext. 120 psears@gmlogic.com
Kimberly O’Shea Communications Manager etrials Worldwide, Inc. 919.653.3601 kimberly.o’shea@etrials.com
Posted: July 2007
